http://pr.gaeatimes.com Thu, 01 Dec 2011 15:05:17 +0000 http://wordpress.org/?v=2.7.1 en hourly 1 http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/ http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/#comments Thu, 01 Dec 2011 05:00:00 +0000 Mylan Inc. http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/ Original article on Gaea Times at  : Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS.]]> http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/feed/ http://pr.gaeatimes.com/eurartesim%c2%ae-dihydroartemisinin-piperaquine-act-to-combat-malaria-receives-marketing-authorization-from-ema-54078/ http://pr.gaeatimes.com/eurartesim%c2%ae-dihydroartemisinin-piperaquine-act-to-combat-malaria-receives-marketing-authorization-from-ema-54078/#comments Wed, 30 Nov 2011 05:00:00 +0000 Sigma-tau Group http://pr.gaeatimes.com/eurartesim%c2%ae-dihydroartemisinin-piperaquine-act-to-combat-malaria-receives-marketing-authorization-from-ema-54078/ Source article  : Eurartesim® (dihydroartemisinin-piperaquine) ACT to Combat Malaria Receives Marketing Authorization From EMA.]]> http://pr.gaeatimes.com/eurartesim%c2%ae-dihydroartemisinin-piperaquine-act-to-combat-malaria-receives-marketing-authorization-from-ema-54078/feed/ http://pr.gaeatimes.com/nice-issues-updated-guidance-for-mr-guided-focused-ultrasound-for-uterine-fibroids-53910/ http://pr.gaeatimes.com/nice-issues-updated-guidance-for-mr-guided-focused-ultrasound-for-uterine-fibroids-53910/#comments Sun, 27 Nov 2011 05:00:00 +0000 Insightec Ltd http://pr.gaeatimes.com/nice-issues-updated-guidance-for-mr-guided-focused-ultrasound-for-uterine-fibroids-53910/ Read more >>.]]> http://pr.gaeatimes.com/nice-issues-updated-guidance-for-mr-guided-focused-ultrasound-for-uterine-fibroids-53910/feed/ http://pr.gaeatimes.com/shire-announces-regulatory-filings-in-us-and-eu-for-new-manufacturing-facility-53785/ http://pr.gaeatimes.com/shire-announces-regulatory-filings-in-us-and-eu-for-new-manufacturing-facility-53785/#comments Tue, 22 Nov 2011 05:00:00 +0000 Shire Pharmaceuticals Group http://pr.gaeatimes.com/shire-announces-regulatory-filings-in-us-and-eu-for-new-manufacturing-facility-53785/ Shire Announces Regulatory Filings in US and EU for New Manufacturing Facility.]]> http://pr.gaeatimes.com/shire-announces-regulatory-filings-in-us-and-eu-for-new-manufacturing-facility-53785/feed/ http://pr.gaeatimes.com/fda-approves-belotero-balance%c2%ae-success-of-a-promising-partnership-between-anteis-and-merz-aesthetics-53664/ http://pr.gaeatimes.com/fda-approves-belotero-balance%c2%ae-success-of-a-promising-partnership-between-anteis-and-merz-aesthetics-53664/#comments Mon, 21 Nov 2011 05:00:00 +0000 Anteis http://pr.gaeatimes.com/fda-approves-belotero-balance%c2%ae-success-of-a-promising-partnership-between-anteis-and-merz-aesthetics-53664/ Source  : FDA Approves BELOTERO Balance®: Success of a Promising Partnership Between Anteis and Merz Aesthetics.]]> http://pr.gaeatimes.com/fda-approves-belotero-balance%c2%ae-success-of-a-promising-partnership-between-anteis-and-merz-aesthetics-53664/feed/ http://pr.gaeatimes.com/caprelsa%e2%84%a2-vandetanib-receives-positive-chmp-opinion-in-the-european-union-for-treating-advanced-medullary-thyroid-cancer-53621/ http://pr.gaeatimes.com/caprelsa%e2%84%a2-vandetanib-receives-positive-chmp-opinion-in-the-european-union-for-treating-advanced-medullary-thyroid-cancer-53621/#comments Fri, 18 Nov 2011 05:00:00 +0000 Astrazeneca http://pr.gaeatimes.com/caprelsa%e2%84%a2-vandetanib-receives-positive-chmp-opinion-in-the-european-union-for-treating-advanced-medullary-thyroid-cancer-53621/ CAPRELSA™ (vandetanib) Receives Positive CHMP Opinion in the European Union for Treating Advanced Medullary Thyroid Cancer.]]> http://pr.gaeatimes.com/caprelsa%e2%84%a2-vandetanib-receives-positive-chmp-opinion-in-the-european-union-for-treating-advanced-medullary-thyroid-cancer-53621/feed/ http://pr.gaeatimes.com/idev-technologies-receives-fda-clearance-for-its-supera-veritas%c2%ae-6-french-stent-delivery-system-53218/ http://pr.gaeatimes.com/idev-technologies-receives-fda-clearance-for-its-supera-veritas%c2%ae-6-french-stent-delivery-system-53218/#comments Thu, 10 Nov 2011 05:00:00 +0000 Idev Technologies Incorporated http://pr.gaeatimes.com/idev-technologies-receives-fda-clearance-for-its-supera-veritas%c2%ae-6-french-stent-delivery-system-53218/ Read the original article on Gaea Times at : IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System.]]> http://pr.gaeatimes.com/idev-technologies-receives-fda-clearance-for-its-supera-veritas%c2%ae-6-french-stent-delivery-system-53218/feed/ http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-next-generation-xience-prime%e2%84%a2-drug-eluting-stent-52724/ http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-next-generation-xience-prime%e2%84%a2-drug-eluting-stent-52724/#comments Tue, 01 Nov 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-next-generation-xience-prime%e2%84%a2-drug-eluting-stent-52724/ Read more : Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent.]]> http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-next-generation-xience-prime%e2%84%a2-drug-eluting-stent-52724/feed/ http://pr.gaeatimes.com/pharmaxis-announces-major-milestone-positive-bronchitol-opinion-for-europe-52431/ http://pr.gaeatimes.com/pharmaxis-announces-major-milestone-positive-bronchitol-opinion-for-europe-52431/#comments Wed, 26 Oct 2011 05:00:00 +0000 Pharmaxis http://pr.gaeatimes.com/pharmaxis-announces-major-milestone-positive-bronchitol-opinion-for-europe-52431/ Read more »».]]> http://pr.gaeatimes.com/pharmaxis-announces-major-milestone-positive-bronchitol-opinion-for-europe-52431/feed/ http://pr.gaeatimes.com/syneron-announces-the-global-launch-of-the-etwo%e2%84%a2-a-new-combination-of-advanced-technologies-for-facial-treatments-52143/ http://pr.gaeatimes.com/syneron-announces-the-global-launch-of-the-etwo%e2%84%a2-a-new-combination-of-advanced-technologies-for-facial-treatments-52143/#comments Thu, 20 Oct 2011 05:00:00 +0000 Syneron Medical Ltd http://pr.gaeatimes.com/syneron-announces-the-global-launch-of-the-etwo%e2%84%a2-a-new-combination-of-advanced-technologies-for-facial-treatments-52143/ Gaea News Network.]]> http://pr.gaeatimes.com/syneron-announces-the-global-launch-of-the-etwo%e2%84%a2-a-new-combination-of-advanced-technologies-for-facial-treatments-52143/feed/ http://pr.gaeatimes.com/agendia-successfully-completes-bi-annual-fda-inspection-51257/ http://pr.gaeatimes.com/agendia-successfully-completes-bi-annual-fda-inspection-51257/#comments Mon, 03 Oct 2011 05:00:00 +0000 Agendia B.v. http://pr.gaeatimes.com/agendia-successfully-completes-bi-annual-fda-inspection-51257/ Agendia Successfully Completes Bi-Annual FDA Inspection.]]> http://pr.gaeatimes.com/agendia-successfully-completes-bi-annual-fda-inspection-51257/feed/ http://pr.gaeatimes.com/synapse-biomedical-receives-fda-approval-for-neurx-diaphragm-pacing-system-dps%c2%ae-to-treat-amyotrophic-lateral-sclerosis-als-51146/ http://pr.gaeatimes.com/synapse-biomedical-receives-fda-approval-for-neurx-diaphragm-pacing-system-dps%c2%ae-to-treat-amyotrophic-lateral-sclerosis-als-51146/#comments Thu, 29 Sep 2011 05:00:00 +0000 Synapse Biomedical Inc. http://pr.gaeatimes.com/synapse-biomedical-receives-fda-approval-for-neurx-diaphragm-pacing-system-dps%c2%ae-to-treat-amyotrophic-lateral-sclerosis-als-51146/ Read more : Synapse Biomedical Receives FDA Approval for NeuRx Diaphragm Pacing System (DPS)® to Treat Amyotrophic Lateral Sclerosis (ALS).]]> http://pr.gaeatimes.com/synapse-biomedical-receives-fda-approval-for-neurx-diaphragm-pacing-system-dps%c2%ae-to-treat-amyotrophic-lateral-sclerosis-als-51146/feed/ http://pr.gaeatimes.com/fda-approves-shires-firazyr%c2%ae-icatibant-injection-for-acute-attacks-of-hereditary-angioedema-hae-49512/ http://pr.gaeatimes.com/fda-approves-shires-firazyr%c2%ae-icatibant-injection-for-acute-attacks-of-hereditary-angioedema-hae-49512/#comments Thu, 25 Aug 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/fda-approves-shires-firazyr%c2%ae-icatibant-injection-for-acute-attacks-of-hereditary-angioedema-hae-49512/ FDA Approves Shire’s FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE).]]> http://pr.gaeatimes.com/fda-approves-shires-firazyr%c2%ae-icatibant-injection-for-acute-attacks-of-hereditary-angioedema-hae-49512/feed/ http://pr.gaeatimes.com/global-crossing-announces-government-certification-for-psn-services-49065/ http://pr.gaeatimes.com/global-crossing-announces-government-certification-for-psn-services-49065/#comments Mon, 15 Aug 2011 05:00:00 +0000 Global Crossing http://pr.gaeatimes.com/global-crossing-announces-government-certification-for-psn-services-49065/ Original source on Gaea Times at : Global Crossing Announces Government Certification for PSN Services.]]> http://pr.gaeatimes.com/global-crossing-announces-government-certification-for-psn-services-49065/feed/ http://pr.gaeatimes.com/nice-recommends-ozurdexr-an-innovative-treatment-for-retinal-vein-occlusion-rvo-a-common-cause-of-vision-loss-48446/ http://pr.gaeatimes.com/nice-recommends-ozurdexr-an-innovative-treatment-for-retinal-vein-occlusion-rvo-a-common-cause-of-vision-loss-48446/#comments Wed, 27 Jul 2011 05:00:00 +0000 Allergan http://pr.gaeatimes.com/nice-recommends-ozurdexr-an-innovative-treatment-for-retinal-vein-occlusion-rvo-a-common-cause-of-vision-loss-48446/ Original article on : NICE Recommends OZURDEX(R), an Innovative Treatment for Retinal Vein Occlusion (RVO), a Common Cause of Vision Loss.]]> http://pr.gaeatimes.com/nice-recommends-ozurdexr-an-innovative-treatment-for-retinal-vein-occlusion-rvo-a-common-cause-of-vision-loss-48446/feed/ http://pr.gaeatimes.com/ema-accepts-eisais-license-extension-application-for-zonegran-zonisamide-in-epilepsy-48461/ http://pr.gaeatimes.com/ema-accepts-eisais-license-extension-application-for-zonegran-zonisamide-in-epilepsy-48461/#comments Wed, 27 Jul 2011 05:00:00 +0000 Eisai Europe Limited http://pr.gaeatimes.com/ema-accepts-eisais-license-extension-application-for-zonegran-zonisamide-in-epilepsy-48461/ Gaea News Network.]]> http://pr.gaeatimes.com/ema-accepts-eisais-license-extension-application-for-zonegran-zonisamide-in-epilepsy-48461/feed/ http://pr.gaeatimes.com/incivor-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-for-the-treatment-of-genotype-1-hepatitis-c-virus-hcv-48294/ http://pr.gaeatimes.com/incivor-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-for-the-treatment-of-genotype-1-hepatitis-c-virus-hcv-48294/#comments Fri, 22 Jul 2011 05:00:00 +0000 Tibotec Virco-virology Bvba http://pr.gaeatimes.com/incivor-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-for-the-treatment-of-genotype-1-hepatitis-c-virus-hcv-48294/ INCIVO(R) Receives Positive Opinion From the Committee for Medicinal Products for Human use (CHMP) for the Treatment of Genotype-1 Hepatitis C Virus (HCV).]]> http://pr.gaeatimes.com/incivor-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-for-the-treatment-of-genotype-1-hepatitis-c-virus-hcv-48294/feed/ http://pr.gaeatimes.com/taiho-pharmaceutical-co-ltd-and-nordic-group-bv-enter-into-a-development-and-commercialization-agreement-for-the-recently-ema-approved-anti-cancer-drug-teysunotm-covering-the-eu-and-other-selected-48231/ http://pr.gaeatimes.com/taiho-pharmaceutical-co-ltd-and-nordic-group-bv-enter-into-a-development-and-commercialization-agreement-for-the-recently-ema-approved-anti-cancer-drug-teysunotm-covering-the-eu-and-other-selected-48231/#comments Thu, 21 Jul 2011 05:00:00 +0000 Nordic Group And Taiho Pharmaceutical Co. Ltd http://pr.gaeatimes.com/taiho-pharmaceutical-co-ltd-and-nordic-group-bv-enter-into-a-development-and-commercialization-agreement-for-the-recently-ema-approved-anti-cancer-drug-teysunotm-covering-the-eu-and-other-selected-48231/ Taiho Pharmaceutical Co., Ltd and Nordic Group BV Enter Into a Development and Commercialization Agreement for the Recently EMA Approved Anti-Cancer Drug Teysuno[TM] Covering the EU and Other Selected European Countries.]]> http://pr.gaeatimes.com/taiho-pharmaceutical-co-ltd-and-nordic-group-bv-enter-into-a-development-and-commercialization-agreement-for-the-recently-ema-approved-anti-cancer-drug-teysunotm-covering-the-eu-and-other-selected-48231/feed/ http://pr.gaeatimes.com/shire-plc-lialda%c2%ae-mesalamine-now-approved-in-us-for-maintenance-of-remission-of-ulcerative-colitis-48047/ http://pr.gaeatimes.com/shire-plc-lialda%c2%ae-mesalamine-now-approved-in-us-for-maintenance-of-remission-of-ulcerative-colitis-48047/#comments Mon, 18 Jul 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-plc-lialda%c2%ae-mesalamine-now-approved-in-us-for-maintenance-of-remission-of-ulcerative-colitis-48047/ Shire plc: Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis.]]> http://pr.gaeatimes.com/shire-plc-lialda%c2%ae-mesalamine-now-approved-in-us-for-maintenance-of-remission-of-ulcerative-colitis-48047/feed/ http://pr.gaeatimes.com/sequana-medical-receives-ce-mark-approval-for-the-alfapump%e2%84%a2-system-and-adds-key-executive-to-team-47855/ http://pr.gaeatimes.com/sequana-medical-receives-ce-mark-approval-for-the-alfapump%e2%84%a2-system-and-adds-key-executive-to-team-47855/#comments Wed, 13 Jul 2011 05:00:00 +0000 Sequana Medical Ag http://pr.gaeatimes.com/sequana-medical-receives-ce-mark-approval-for-the-alfapump%e2%84%a2-system-and-adds-key-executive-to-team-47855/ Read the original article  : Sequana Medical Receives CE Mark Approval for the ALFApump™ System and Adds Key Executive to Team.]]> http://pr.gaeatimes.com/sequana-medical-receives-ce-mark-approval-for-the-alfapump%e2%84%a2-system-and-adds-key-executive-to-team-47855/feed/ http://pr.gaeatimes.com/23-patients-with-organ-confined-low-risk-prostate-cancer-have-been-treated-in-clinical-trials-using-the-exablater-non-invasive-prostate-cancer-system-47892/ http://pr.gaeatimes.com/23-patients-with-organ-confined-low-risk-prostate-cancer-have-been-treated-in-clinical-trials-using-the-exablater-non-invasive-prostate-cancer-system-47892/#comments Wed, 13 Jul 2011 05:00:00 +0000 Insightec Ltd http://pr.gaeatimes.com/23-patients-with-organ-confined-low-risk-prostate-cancer-have-been-treated-in-clinical-trials-using-the-exablater-non-invasive-prostate-cancer-system-47892/ Read more : 23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials Using the ExAblate(R) Non-Invasive Prostate Cancer System.]]> http://pr.gaeatimes.com/23-patients-with-organ-confined-low-risk-prostate-cancer-have-been-treated-in-clinical-trials-using-the-exablater-non-invasive-prostate-cancer-system-47892/feed/ http://pr.gaeatimes.com/omnilife-science-inc-announces-ps-knee-fda-clearance-47543/ http://pr.gaeatimes.com/omnilife-science-inc-announces-ps-knee-fda-clearance-47543/#comments Tue, 05 Jul 2011 05:00:00 +0000 Omnilife Science Inc. http://pr.gaeatimes.com/omnilife-science-inc-announces-ps-knee-fda-clearance-47543/ Read the original article  : OMNIlife science, Inc. Announces PS Knee FDA Clearance.]]> http://pr.gaeatimes.com/omnilife-science-inc-announces-ps-knee-fda-clearance-47543/feed/ http://pr.gaeatimes.com/fda-approves-lazanda%c2%ae-first-fentanyl-nasal-spray-for-the-management-of-breakthrough-pain-in-cancer-patients-47421/ http://pr.gaeatimes.com/fda-approves-lazanda%c2%ae-first-fentanyl-nasal-spray-for-the-management-of-breakthrough-pain-in-cancer-patients-47421/#comments Thu, 30 Jun 2011 05:00:00 +0000 Archimedes Pharma Ltd. http://pr.gaeatimes.com/fda-approves-lazanda%c2%ae-first-fentanyl-nasal-spray-for-the-management-of-breakthrough-pain-in-cancer-patients-47421/ Original article on Gaea Times at  : FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients.]]> http://pr.gaeatimes.com/fda-approves-lazanda%c2%ae-first-fentanyl-nasal-spray-for-the-management-of-breakthrough-pain-in-cancer-patients-47421/feed/ http://pr.gaeatimes.com/fda-advisory-committee-strongly-recommends-approval-and-self-administration-of-firazyr%c2%ae-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-47059/ http://pr.gaeatimes.com/fda-advisory-committee-strongly-recommends-approval-and-self-administration-of-firazyr%c2%ae-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-47059/#comments Thu, 23 Jun 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/fda-advisory-committee-strongly-recommends-approval-and-self-administration-of-firazyr%c2%ae-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-47059/ FDA Advisory Committee Strongly Recommends Approval and Self-Administration of FIRAZYR® (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema.]]> http://pr.gaeatimes.com/fda-advisory-committee-strongly-recommends-approval-and-self-administration-of-firazyr%c2%ae-icatibant-for-the-treatment-of-acute-attacks-of-hereditary-angioedema-47059/feed/ http://pr.gaeatimes.com/fujirebio-diagnostics-inc-receives-fda-510-k-clearance-for-first-biomarker-to-monitor-lung-cancer-45949/ http://pr.gaeatimes.com/fujirebio-diagnostics-inc-receives-fda-510-k-clearance-for-first-biomarker-to-monitor-lung-cancer-45949/#comments Tue, 31 May 2011 05:00:00 +0000 Fujirebio Diagnostics Inc. http://pr.gaeatimes.com/fujirebio-diagnostics-inc-receives-fda-510-k-clearance-for-first-biomarker-to-monitor-lung-cancer-45949/ Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer.]]> http://pr.gaeatimes.com/fujirebio-diagnostics-inc-receives-fda-510-k-clearance-for-first-biomarker-to-monitor-lung-cancer-45949/feed/ http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letters-45708/ http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letters-45708/#comments Wed, 25 May 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letters-45708/ Shire Receives VYVANSE(R) Paragraph IV Notice Letters.]]> http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letters-45708/feed/ http://pr.gaeatimes.com/optimization-of-cardiac-resynchronization-therapy-using-cheetah-medicals-nicomr-hemodynamic-monitoring-system-was-found-to-lead-to-improvement-in-heart-failure-outcomes-45636/ http://pr.gaeatimes.com/optimization-of-cardiac-resynchronization-therapy-using-cheetah-medicals-nicomr-hemodynamic-monitoring-system-was-found-to-lead-to-improvement-in-heart-failure-outcomes-45636/#comments Tue, 24 May 2011 05:00:00 +0000 Cheetah Medical Ltd http://pr.gaeatimes.com/optimization-of-cardiac-resynchronization-therapy-using-cheetah-medicals-nicomr-hemodynamic-monitoring-system-was-found-to-lead-to-improvement-in-heart-failure-outcomes-45636/ Original source  : Optimization of Cardiac Resynchronization Therapy Using Cheetah Medical's NICOM(R) Hemodynamic Monitoring System was Found to Lead to Improvement in Heart Failure Outcomes.]]> http://pr.gaeatimes.com/optimization-of-cardiac-resynchronization-therapy-using-cheetah-medicals-nicomr-hemodynamic-monitoring-system-was-found-to-lead-to-improvement-in-heart-failure-outcomes-45636/feed/ http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-xience-nanotm-to-treat-coronary-artery-disease-in-small-vessels-45670/ http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-xience-nanotm-to-treat-coronary-artery-disease-in-small-vessels-45670/#comments Tue, 24 May 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-xience-nanotm-to-treat-coronary-artery-disease-in-small-vessels-45670/ Read more >>.]]> http://pr.gaeatimes.com/abbott-receives-us-fda-approval-for-xience-nanotm-to-treat-coronary-artery-disease-in-small-vessels-45670/feed/ http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letter-45441/ http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letter-45441/#comments Thu, 19 May 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letter-45441/ Read : Shire Receives VYVANSE(R) Paragraph IV Notice Letter.]]> http://pr.gaeatimes.com/shire-receives-vyvanser-paragraph-iv-notice-letter-45441/feed/ http://pr.gaeatimes.com/premia-spine-acquires-assets-of-impliant-45447/ http://pr.gaeatimes.com/premia-spine-acquires-assets-of-impliant-45447/#comments Thu, 19 May 2011 05:00:00 +0000 Premia Spine Ltd http://pr.gaeatimes.com/premia-spine-acquires-assets-of-impliant-45447/ Premia Spine Acquires Assets of Impliant.]]> http://pr.gaeatimes.com/premia-spine-acquires-assets-of-impliant-45447/feed/